1 / 5

Total spending ($)

Figure 1. Relationship of Drug Spending to Total Medical Spending for Community-Dwelling Medicare Beneficiaries, 2002. Total spending ($). Spending Decile. Figure 2. Prescription Drug Spending as a Percent of Total Medical Spending for Community-Dwelling Medicare Beneficiaries, 2002. Percent.

tinker
Télécharger la présentation

Total spending ($)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 1. Relationship of Drug Spending to Total MedicalSpending for Community-Dwelling Medicare Beneficiaries, 2002 Total spending ($) Spending Decile

  2. Figure 2. Prescription Drug Spending as a Percent of Total Medical Spending for Community-Dwelling Medicare Beneficiaries, 2002 Percent Spending Decile

  3. Figure 3. Relationship of Drug Use to Medication-IntensiveConditions (RxHCCs) for Community-DwellingMedicare Beneficiaries, 2002 Number Spending Decile * Adjusted to account for combination products containing drugs in two or more pharmacologic classes.

  4. Figure 4. Intensity of Prescription Drug Use perMedication-Intensive Condition (RxHCC) forCommunity-Dwelling Medicare Beneficiaries, 2002 Number Spending Decile * Adjusted to account for combination products containing drugs in two or more pharmacologic classes.

  5. Figure 5. Intensity of Prescription Drug Use per Pharmacologic Class for Community-Dwelling Medicare Beneficiaries, 2002 Number Spending Decile * Adjusted to account for combination products containing drugs in two or more pharmacologic classes.

More Related